泰诺麦博登上2024年VBEF双榜单，斯泰度塔单抗注射液获“创新力产品”称号
近日，第八届未来医疗生态展会在北京举行。会上，2024年未来医疗100强榜单正式揭晓。珠海泰诺麦博制药股份有限公司（以下简称“泰诺麦博”）凭借其在医疗健康领域展现出的创新力和行业贡献，登上“中国创新医药与生物制品榜TOP100”。与此同时由泰诺麦博自主研发的斯泰度塔单抗注射液在众多产品中脱颖而出，登上 来源链接
RECOMMENDED
TRENDING
Precious Metals Market Surges with Growing Demand in Jewelry and Industrial Applications as per Maximize Research
(EMAILWIRE.COM, May 18, 2025 ) Precious Metals Market to Hit USD 564.96 Bn by 2032Precious Metals Market...
Asiana.Network™ is a network of news sites focused on the following sub regions of Asia: Asia Pacific, Central Asia, East Asia, South Asia and South East Asia. Asian.Network™ aggregates and publishes news in Mandarin Chinese, Hindi, Indonesian, Bengali, Japanese, Vietnamese and English. In Association with AsiaNewswire.Net™,Asiana.Network™ also publishes and distributes press releases to media in the sub regions and the entire Asia. For press release distribution to media in Asia contact us through messaging apps.